Thursday, January 18, 2024 10:59:37 AM
AS FAST AS YOU CAN !! WE'RE VERY CLOSE !!
Recent CELU News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 09:15:11 PM
- Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023 • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/30/2024 08:26:55 PM
- Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 06/03/2024 12:38:39 PM
- Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing • GlobeNewswire Inc. • 05/24/2024 09:15:00 PM
- Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy • GlobeNewswire Inc. • 05/14/2024 01:15:00 PM
- Celularity Inc. to Host Investor and Analyst Research & Development Day • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing • GlobeNewswire Inc. • 04/19/2024 09:30:00 PM
- Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 • GlobeNewswire Inc. • 04/18/2024 08:30:00 PM
- Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells • GlobeNewswire Inc. • 04/08/2024 01:00:00 PM
- Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L • GlobeNewswire Inc. • 03/26/2024 01:00:00 PM
- Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy • GlobeNewswire Inc. • 03/20/2024 01:15:00 PM
- Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit • GlobeNewswire Inc. • 03/14/2024 01:15:00 PM
- Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress • GlobeNewswire Inc. • 03/12/2024 01:20:51 PM
- Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells • GlobeNewswire Inc. • 03/07/2024 02:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:15:23 PM
- Celularity Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 02/23/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 02:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:38:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:22:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:18:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:14:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:10:27 AM
- Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease • GlobeNewswire Inc. • 02/14/2024 09:05:00 PM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM